Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years

Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years Curr Sex Health Rep (2017) 9:277–289 https://doi.org/10.1007/s11930-017-0132-3 MEDICAL COMORBIDITIES (M MINER, S PARISH AND A GOLDSTEIN, SECTION EDITORS) Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years 1 2 3 1 Giovanni Corona & Giulia Rastrelli & Mauro Dicuio & Alessandra Sforza & Mario Maggi Published online: 16 November 2017 Springer Science+Business Media, LLC 2017 Abstract protective role of TTh on CV risk; however, data from RCTs Purpose of the Review The relationship between the age- and their meta-analysis, presented here, do not provide us with dependent decline of testosterone (T) and cardiovascular sufficient information on this point. (CV) risk in men is still a matter of intense debate. In particular, Summary Present data do not indicate an increased risk with over the last 5 years, several scientific reports have shed a new TTh, but there is also insufficient definitive evidence that TTh negative light on the association between T treatment (TTh) is protective. Therefore, further and more specific trials are and forthcoming CV diseases (CVD). Based on this evidence, advisable to better clarify the possible relationship between the US Food and Drug Administration agency has recom- low T, TTh, and CVD in aging http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Sexual Health Reports Springer Journals

Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years

Loading next page...
1
 
/lp/springer_journal/testosterone-and-cardiovascular-diseases-causes-or-consequences-the-LfUQzeAmr2

References (82)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Urology; Endocrinology
ISSN
1548-3584
eISSN
1548-3592
DOI
10.1007/s11930-017-0132-3
Publisher site
See Article on Publisher Site

Abstract

Curr Sex Health Rep (2017) 9:277–289 https://doi.org/10.1007/s11930-017-0132-3 MEDICAL COMORBIDITIES (M MINER, S PARISH AND A GOLDSTEIN, SECTION EDITORS) Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years 1 2 3 1 Giovanni Corona & Giulia Rastrelli & Mauro Dicuio & Alessandra Sforza & Mario Maggi Published online: 16 November 2017 Springer Science+Business Media, LLC 2017 Abstract protective role of TTh on CV risk; however, data from RCTs Purpose of the Review The relationship between the age- and their meta-analysis, presented here, do not provide us with dependent decline of testosterone (T) and cardiovascular sufficient information on this point. (CV) risk in men is still a matter of intense debate. In particular, Summary Present data do not indicate an increased risk with over the last 5 years, several scientific reports have shed a new TTh, but there is also insufficient definitive evidence that TTh negative light on the association between T treatment (TTh) is protective. Therefore, further and more specific trials are and forthcoming CV diseases (CVD). Based on this evidence, advisable to better clarify the possible relationship between the US Food and Drug Administration agency has recom- low T, TTh, and CVD in aging

Journal

Current Sexual Health ReportsSpringer Journals

Published: Nov 16, 2017

There are no references for this article.